| Dr Matthew Robert Thom, MD | |
|
701 University Blvd E, Suite 908, Tuscaloosa, AL 35401-2086 | |
| (205) 344-9393 | |
| (205) 759-7744 |
| Full Name | Dr Matthew Robert Thom |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 13 Years |
| Location | 701 University Blvd E, Tuscaloosa, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942234414 | NPI | - | NPPES |
| 102I346537 | Other | AL | MEDICARE |
| 129502 | Medicaid | AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 30929 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| D C H Regional Medical Center | Tuscaloosa, AL | Hospital |
| Fayette Medical Center | Fayette, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| West Alabama Physician Associates Llc | 3476620311 | 22 |
News Archive
The cancer agency of the World Health Organization says drinking very hot beverages is probably associated with esophageal cancer.
David J. Brailer, MD, PhD, Chairman of Health Evolution Partners, announced the firm's release of the 2010 Health Industry Landscape Report.
Scientists at the Gladstone Institutes have identified a finely tuned mechanism by which fetal heart muscle develops into a healthy and fully formed beating heart-offering new insight into the genetic causes of congenital heart disease and opening the door to one day developing therapies to fight this chronic and potentially fatal disorder.
Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today presented first interim data from a phase 1 dose-escalation clinical study for BiTE antibody MT110, the first T-cell engaging antibody for the treatment of solid tumors.
Half as many diagnosed with depression, a delayed manifestation of Parkinson's, a reduced risk of developing vascular dementia - but not Alzheimer's.
› Verified 4 days ago
| Entity Name | Dch Health Care Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841394418 PECOS PAC ID: 8123924248 Enrollment ID: O20040204000874 |
News Archive
The cancer agency of the World Health Organization says drinking very hot beverages is probably associated with esophageal cancer.
David J. Brailer, MD, PhD, Chairman of Health Evolution Partners, announced the firm's release of the 2010 Health Industry Landscape Report.
Scientists at the Gladstone Institutes have identified a finely tuned mechanism by which fetal heart muscle develops into a healthy and fully formed beating heart-offering new insight into the genetic causes of congenital heart disease and opening the door to one day developing therapies to fight this chronic and potentially fatal disorder.
Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today presented first interim data from a phase 1 dose-escalation clinical study for BiTE antibody MT110, the first T-cell engaging antibody for the treatment of solid tumors.
Half as many diagnosed with depression, a delayed manifestation of Parkinson's, a reduced risk of developing vascular dementia - but not Alzheimer's.
› Verified 4 days ago
| Entity Name | West Alabama Physician Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316101769 PECOS PAC ID: 3476620311 Enrollment ID: O20080918000595 |
News Archive
The cancer agency of the World Health Organization says drinking very hot beverages is probably associated with esophageal cancer.
David J. Brailer, MD, PhD, Chairman of Health Evolution Partners, announced the firm's release of the 2010 Health Industry Landscape Report.
Scientists at the Gladstone Institutes have identified a finely tuned mechanism by which fetal heart muscle develops into a healthy and fully formed beating heart-offering new insight into the genetic causes of congenital heart disease and opening the door to one day developing therapies to fight this chronic and potentially fatal disorder.
Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today presented first interim data from a phase 1 dose-escalation clinical study for BiTE antibody MT110, the first T-cell engaging antibody for the treatment of solid tumors.
Half as many diagnosed with depression, a delayed manifestation of Parkinson's, a reduced risk of developing vascular dementia - but not Alzheimer's.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Matthew Robert Thom, MD 701 University Blvd E, Suite 908, Tuscaloosa, AL 35401-2086 Ph: (205) 344-9393 | Dr Matthew Robert Thom, MD 701 University Blvd E, Suite 908, Tuscaloosa, AL 35401-2086 Ph: (205) 344-9393 |
News Archive
The cancer agency of the World Health Organization says drinking very hot beverages is probably associated with esophageal cancer.
David J. Brailer, MD, PhD, Chairman of Health Evolution Partners, announced the firm's release of the 2010 Health Industry Landscape Report.
Scientists at the Gladstone Institutes have identified a finely tuned mechanism by which fetal heart muscle develops into a healthy and fully formed beating heart-offering new insight into the genetic causes of congenital heart disease and opening the door to one day developing therapies to fight this chronic and potentially fatal disorder.
Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today presented first interim data from a phase 1 dose-escalation clinical study for BiTE antibody MT110, the first T-cell engaging antibody for the treatment of solid tumors.
Half as many diagnosed with depression, a delayed manifestation of Parkinson's, a reduced risk of developing vascular dementia - but not Alzheimer's.
› Verified 4 days ago
Kenneth W Aldridge, MD Urology Medicare: Medicare Enrolled Practice Location: 701 University Blvd E, Suite 908, Tuscaloosa, AL 35401 Phone: 205-344-9393 Fax: 205-758-6750 | |
John W Duffy Iii, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1780 Mcfarland Blvd N, Tuscaloosa, AL 35406 Phone: 205-345-7351 Fax: 205-345-8476 | |
Dr. Howard N Winfield, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 701 University Blvd E, Suite 908, Tuscaloosa, AL 35401 Phone: 205-344-9393 Fax: 205-759-7744 | |
Ingrum W Bankston Jr., M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1780 Mcfarland Blvd N, Tuscaloosa, AL 35406 Phone: 205-345-7351 Fax: 205-345-8476 | |
Raymond E Poore Jr., M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 1780 Mcfarland Blvd N, Tuscaloosa, AL 35406 Phone: 205-345-7351 Fax: 205-345-8476 | |
Dr. Winston Murphree Crute, MD Urology Medicare: Medicare Enrolled Practice Location: 1780 Mcfarland Blvd N, Tuscaloosa, AL 35406 Phone: 205-345-7351 Fax: 205-345-8476 |